au.\*:("DAVIS, K. L")
Results 1 to 25 of 158
Selection :
RESULTS OF THE 1973 ASSOCIATION OF TEACHER EDUCATION HUMAN RELATIONS TRAINING SUMMER WORKSHOPDAVIS K. L; GAZDA G. M.EDUCATION. 1975, Vol 96, Num 2, pp 184-189Article
Strategies for the treatment of Alzheimer's diseaseDAVIS, K. L; VAHRAM HAROUTUNIAN.Neurology. 1993, Vol 43, Num 8, pp S52-S55, issn 0028-3878, SUP4Article
Correlation between elevated Levels of amyloid β-peptide in the brain and cognitive declineNÄSLUND, J; HAROUTUNIAN, V; MOHS, R et al.JAMA, the journal of the American Medical Association. 2000, Vol 283, Num 12, pp 1571-1577, issn 0098-7484Article
Has familial aggregation in Alzheimer's disease been overestimated ?SILVERMAN, J. M; SMITH, C. M; MARIN, D. B et al.International journal of geriatric psychiatry. 2000, Vol 15, Num 7, pp 631-637, issn 0885-6230Article
The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophreniaMCGURK, S. R; MORIARTY, P. J; HARVEY, P. D et al.Schizophrenia research. 2000, Vol 42, Num 1, pp 47-55, issn 0920-9964Article
Mechanisms of killing of spores of Bacillus subtilis by iodine, glutaraldehyde and nitrous acidTENNEN, R; SETLOW, B; DAVIS, K. L et al.Journal of applied microbiology (Print). 2000, Vol 89, Num 2, pp 330-338, issn 1364-5072Article
Cognitive and functional changes with aging in schizophrenia : Schizophrenia : Comments on Genes, Development, Risk Factors, Phenotype, and CourseFRIEDMAN, J. I; HARVEY, P. D; KEMETHER, E et al.Biological psychiatry (1969). 1999, Vol 46, Num 7, pp 921-928, issn 0006-3223Conference Paper
Civic center retrofitCALLAWAY, C. A; DAVIS, K. L; KUEHN, J et al.ASHRAE journal. 1999, Vol 41, Num 12, pp 50-52, issn 0001-2491Article
Pharmacologic strategies for augmenting cognitive performance in schizophreniaFRIEDMAN, J. I; TEMPORINI, H; DAVIS, K. L et al.Biological psychiatry (1969). 1999, Vol 45, Num 1, pp 1-16, issn 0006-3223Article
A risk-benefit assessment of tacrine in the treatment of Alzheimer's diseaseSAMUELS, S. C; DAVIS, K. L.Drug safety. 1997, Vol 16, Num 1, pp 66-77, issn 0114-5916Article
Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophreniaKEEFE, R. S. E; SILVERMAN, J. M; DAVIS, K. L et al.Archives of general psychiatry. 1997, Vol 54, Num 2, pp 169-176, issn 0003-990XArticle
Regulation of microvascular filtration in the myocardium by interstitial fluid pressureSTEWART, R. H; ROHN, D. A; MEHLHORN, U et al.American journal of physiology. Regulatory, integrative and comparative physiology. 1996, Vol 40, Num 6, pp R1465-R1469, issn 0363-6119Article
Impact of cardiopulmonary bypass and cardioplegic arrest on myocardial lymphatic functionMEHLHORN, U; DAVIS, K. L; BURKE, E. J et al.American journal of physiology. Heart and circulatory physiology. 1995, Vol 37, Num 1, pp H178-H183, issn 0363-6135Article
Myocardial edema, left ventricular function, and pulmonary hypertensionDAVIS, K. L; MEHLHORN, U; LAINE, G. A et al.Journal of applied physiology (1985). 1995, Vol 78, Num 1, pp 132-137, issn 8750-7587Article
A pilot study of clonidine plus physostigmine in Alzheimer's diseaseBIERER, L. M; AISEN, P. S; DAVIDSON, M et al.Dementia (Basel). 1994, Vol 5, Num 5, pp 243-246, issn 1013-7424Article
Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's diseasePERRY, E. K; HAROUTUNIAN, V; PERRY, R. H et al.Neuroreport (Oxford). 1994, Vol 5, Num 7, pp 747-749, issn 0959-4965Article
Inhibition of the active lymph pump in rat mesenteric lymphatics by hydrogen peroxideZAWIEJA, D. C; DAVIS, K. L.Lymphology. 1993, Vol 26, Num 3, pp 135-142, issn 0024-7766Article
Acrylamide polymerization kinetics in gell electrophoresis capillaries. A raman microprobe studyRAPP, T. L; KOWALCHYK, W. K; DAVIS, K. L et al.Analytical chemistry (Washington, DC). 1992, Vol 64, Num 20, pp 2434-2437, issn 0003-2700Article
Empirical assessment of the factorial structure of clinical symptoms in schizophrenia : negative symptomsKEEFE, R. S. E; HARVEY, P. D; LENZENWEGER, M. F et al.Psychiatry research. 1992, Vol 44, Num 2, pp 153-165, issn 0165-1781Article
Effects of indomethacin on plasma homovanillic acid concentration in normal subjects : a study of prostaglandin-dopamine interactionsKAHN, R. S; DAVIDSON, M; KANOF, P et al.Psychopharmacologia. 1991, Vol 103, Num 1, pp 95-98, issn 0033-3158, 4 p.Article
Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrationsDAVIDSON, M; KAHN, R. S; KNOTT, P et al.Archives of general psychiatry. 1991, Vol 48, Num 10, pp 910-913, issn 0003-990XArticle
Therapeutic trials using tracine and other cholinesterase inhibitorsGAMZU, E. R; THAL, L. J; DAVIS, K. L et al.Advances in neurology. 1990, Vol 51, pp 241-245, issn 0091-3952, 5 p.Article
Attentional markers of vulnerability to schizophrenia performance of medicated and unmedicated patients and normalsHARVEY, P. D; KEEFE, R. S. E; MOSKOWITZ, J et al.Psychiatry research. 1990, Vol 33, Num 2, pp 179-188, issn 0165-1781, 10 p.Article
Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned ratsHAROUTUNIAN, V; KANOF, P. D; TSUBOYAMA, G et al.Brain research. 1990, Vol 507, Num 2, pp 261-266, issn 0006-8993Article
Endocrine changes in Alzheimer's diseaseDAVIDSON, M; BASTIAENS, L; DAVIS, B. M et al.Endocrinology and metabolism clinics of North America. 1988, Vol 17, Num 1, pp 149-157, issn 0889-8529Article